DekaBank Deutsche Girozentrale’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $251K | Hold |
28,300
| – | – | ﹤0.01% | 1088 |
|
2025
Q1 | $361K | Hold |
28,300
| – | – | ﹤0.01% | 1018 |
|
2024
Q4 | $350K | Hold |
28,300
| – | – | ﹤0.01% | 1062 |
|
2024
Q3 | $521K | Hold |
28,300
| – | – | ﹤0.01% | 1004 |
|
2024
Q2 | $564K | Hold |
28,300
| – | – | ﹤0.01% | 985 |
|
2024
Q1 | $636K | Hold |
28,300
| – | – | ﹤0.01% | 958 |
|
2023
Q4 | $597K | Hold |
28,300
| – | – | ﹤0.01% | 1000 |
|
2023
Q3 | $431K | Hold |
28,300
| – | – | ﹤0.01% | 1048 |
|
2023
Q2 | $568K | Hold |
28,300
| – | – | ﹤0.01% | 1004 |
|
2023
Q1 | $572K | Hold |
28,300
| – | – | ﹤0.01% | 990 |
|
2022
Q4 | $683K | Hold |
28,300
| – | – | ﹤0.01% | 965 |
|
2022
Q3 | $687K | Hold |
28,300
| – | – | ﹤0.01% | 980 |
|
2022
Q2 | $529K | Hold |
28,300
| – | – | ﹤0.01% | 1013 |
|
2022
Q1 | $488K | Buy |
28,300
+2,600
| +10% | +$44.8K | ﹤0.01% | 1061 |
|
2021
Q4 | $534K | Buy |
25,700
+700
| +3% | +$14.5K | ﹤0.01% | 1086 |
|
2021
Q3 | $481K | Hold |
25,000
| – | – | ﹤0.01% | 1053 |
|
2021
Q2 | $427K | Hold |
25,000
| – | – | ﹤0.01% | 1101 |
|
2021
Q1 | $517K | Hold |
25,000
| – | – | ﹤0.01% | 1024 |
|
2020
Q4 | $575K | Buy |
+25,000
| New | +$575K | ﹤0.01% | 994 |
|